Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Dissertação de Mestrado
|
![]() |
Frequência do polimorfismo rs12979860, no gene da IL28B, em pacientes portadores de hepatite C crônica e em controles sadios: nova metodologia de baixo custo e menor tempo para genotipagemFerreira, Camila Da SilvaBiblioteca Digital de Teses e Dissertações da USP; Universidade de São Paulo; Faculdade de Medicina 2013-05-08Acesso online. A biblioteca também possui exemplares impressos. |
2 |
Material Type: Artigo
|
![]() |
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionLinas, Benjamin P ; Barter, Devra M ; Morgan, Jake R ; Pho, Mai T ; Leff, Jared A ; Schackman, Bruce R ; Horsburgh, C Robert ; Assoumou, Sabrina A ; Salomon, Joshua A ; Weinstein, Milton C ; Freedberg, Kenneth A ; Kim, Arthur YAnnals of internal medicine, 2015-05, Vol.162 (9), p.619-629 [Periódico revisado por pares]United States: American College of PhysiciansTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysisLiu, Shan ; Cipriano, Lauren E ; Holodniy, Mark ; Owens, Douglas K ; Goldhaber-Fiebert, Jeremy DAnnals of internal medicine, 2012-02, Vol.156 (4), p.279 [Periódico revisado por pares]United States: American College of PhysiciansTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Cost‐effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infectionSaab, S. ; Gordon, S. C. ; Park, H. ; Sulkowski, M. ; Ahmed, A. ; Younossi, Z.Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.657-675 [Periódico revisado por pares]Oxford: BlackwellTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databaseTsai, Pei-Chien ; Liu, Ta-Wei ; Tsai, Yi-Shan ; Ko, Yu-Min ; Chen, Kuan-Yu ; Lin, Ching-Chih ; Huang, Ching-I ; Liang, Po-Cheng ; Lin, Yi-Hung ; Hsieh, Ming-Yen ; Hou, Nai-Jen ; Huang, Chung-Feng ; Yeh, Ming-Lun ; Lin, Zu-Yau ; Chen, Shinn-Cherng ; Dai, Chia-Yen ; Chuang, Wan-Long ; Huang, Jee-Fu ; Yu, Ming-LungMedicine (Baltimore), 2017-06, Vol.96 (22), p.e6984 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluationHartwell, D ; Jones, J ; Baxter, L ; Shepherd, JHealth technology assessment (Winchester, England), 2011-04, Vol.15 (17), p.i-210 [Periódico revisado por pares]England: NIHR Journals LibraryTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South AfricaFraser, Ilanca ; Burger, Johanita ; Lubbe, Martie ; Dranitsaris, George ; Sonderup, Mark ; Stander, TieniePharmacoEconomics, 2016-04, Vol.34 (4), p.403-417 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-respondersTsai, Pei-Chien ; Liu, Ta-Wei ; Huang, Chung-Feng ; Yeh, Ming-Lun ; Dai, Chia-Yen ; Chuang, Wan-Long ; Huang, Jee-Fu ; Yu, Ming-LungJournal of the Chinese Medical Association, 2018-08, Vol.81 (8), p.670-675 [Periódico revisado por pares]Netherlands: Elsevier Taiwan LLCTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6Kapol, Nattiya ; Lochid-Amnuay, Surasit ; Teerawattananon, YotBMC gastroenterology, 2016-08, Vol.16 (1), p.91-91, Article 91 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Update on the treatment of hepatitis C genotypes 2–6Paterson, Jacqueline C.M ; Miller, Michael H ; Dillon, John FCurrent opinion in infectious diseases, 2014-12, Vol.27 (6), p.540-544 [Periódico revisado por pares]United States: Lippincott Williams & Wilkins, IncTexto completo disponível |